NO141850C - Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.

Info

Publication number
NO141850C
NO141850C NO744421A NO744421A NO141850C NO 141850 C NO141850 C NO 141850C NO 744421 A NO744421 A NO 744421A NO 744421 A NO744421 A NO 744421A NO 141850 C NO141850 C NO 141850C
Authority
NO
Norway
Prior art keywords
pyrazold
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO744421A
Other languages
English (en)
Norwegian (no)
Other versions
NO141850B (no
NO744421L (nl
Inventor
Eike Moeller
Karl Meng
Egbert Wehinger
Harald Horstmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO744421L publication Critical patent/NO744421L/no
Publication of NO141850B publication Critical patent/NO141850B/no
Publication of NO141850C publication Critical patent/NO141850C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO744421A 1973-12-20 1974-12-06 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. NO141850C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2363511A DE2363511A1 (de) 1973-12-20 1973-12-20 Pyrazol-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO744421L NO744421L (nl) 1975-07-14
NO141850B NO141850B (no) 1980-02-11
NO141850C true NO141850C (no) 1980-06-04

Family

ID=5901399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744421A NO141850C (no) 1973-12-20 1974-12-06 Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.

Country Status (31)

Country Link
US (1) US4002641A (nl)
JP (1) JPS5851953B2 (nl)
AR (1) AR209430A1 (nl)
AT (1) AT339895B (nl)
BE (1) BE823507A (nl)
BG (1) BG26196A3 (nl)
CA (1) CA1079728A (nl)
CH (2) CH583427A5 (nl)
CS (1) CS181777B2 (nl)
DD (1) DD117455A5 (nl)
DE (1) DE2363511A1 (nl)
DK (1) DK135348C (nl)
EG (1) EG12130A (nl)
ES (1) ES433148A1 (nl)
FI (1) FI57585C (nl)
FR (1) FR2255065B1 (nl)
GB (1) GB1441859A (nl)
HK (1) HK7977A (nl)
HU (1) HU170936B (nl)
IE (1) IE40335B1 (nl)
IL (1) IL46264A (nl)
IN (1) IN141279B (nl)
LU (1) LU71519A1 (nl)
NL (1) NL7416515A (nl)
NO (1) NO141850C (nl)
PH (1) PH12944A (nl)
PL (1) PL93398B1 (nl)
RO (1) RO66906A (nl)
SE (1) SE415834B (nl)
SU (1) SU587860A3 (nl)
ZA (1) ZA748085B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102857A (en) * 1973-07-13 1978-07-25 Sandoz Ltd. Pyrazole derivatives
US4146726A (en) * 1974-03-28 1979-03-27 Sankyo Company Limited Pyrazole sulfonates
US4112109A (en) * 1975-06-13 1978-09-05 Bayer Aktiengesellschaft 4-Substituted pyrazoles
US4117145A (en) * 1975-06-13 1978-09-26 Bayer Aktiengesellschaft 1-substituted pyrazoles
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
US4964895A (en) * 1987-06-08 1990-10-23 Monsanto Company Substituted 4-(4-nitrophenoxy) pyrazoles and their use as herbicides
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB599919A (en) 1944-12-11 1948-03-24 Kodak Ltd Improvements in the manufacture of aminopyrazolones and their use as colour couplers
US2476986A (en) * 1949-07-26 Elmobe louis martin
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
US2476987A (en) * 1949-07-26 S-acyloxy pyrazqles and method foe
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
ZA10401B (nl) * 1949-08-22
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
GB779703A (en) 1953-07-06 1957-07-24 Hoechst Ag Pyrazolone compounds and a process for making them
US2848446A (en) * 1954-02-23 1958-08-19 Saul & Co Azo dyestuffs
US3014916A (en) * 1959-01-22 1961-12-26 May & Baker Ltd Pyrazole derivatives
GB961037A (en) 1960-08-23 1964-06-17 Smith & Nephew Pyrazolones and processes for their preparation
NL279140A (nl) * 1961-05-31
US3190888A (en) * 1963-08-22 1965-06-22 American Home Prod Aryloxyalkylpyrazole
GB1190914A (en) * 1966-09-26 1970-05-06 Agfa Gevaert Nv 2-Pyrazolin-5-Ones and the use thereof as Colour Couplers
GB1247688A (en) 1968-02-26 1971-09-29 Agfa Gevaert Monomeric and polymeric 2-pyrazoline-5-one colour couplers
US3615506A (en) * 1970-02-09 1971-10-26 Eastman Kodak Co Silver halide emulsions containing 3-cyclicamino-5-pyrazolone color couplers

Also Published As

Publication number Publication date
BE823507A (fr) 1975-06-18
FR2255065B1 (nl) 1978-07-28
AT339895B (de) 1977-11-10
CS181777B2 (en) 1978-03-31
LU71519A1 (nl) 1975-08-20
IL46264A0 (en) 1975-03-13
ZA748085B (en) 1976-01-28
NL7416515A (nl) 1975-06-24
DK135348B (da) 1977-04-12
PL93398B1 (nl) 1977-05-30
HU170936B (hu) 1977-10-28
ATA1008774A (de) 1977-03-15
GB1441859A (en) 1976-07-07
SU587860A3 (ru) 1978-01-05
SE7416030L (nl) 1975-06-23
FR2255065A1 (nl) 1975-07-18
FI57585B (fi) 1980-05-30
DD117455A5 (nl) 1976-01-12
IE40335B1 (en) 1979-05-09
IN141279B (nl) 1977-02-12
DK666174A (nl) 1975-08-25
CH583427A5 (nl) 1976-12-31
RO66906A (ro) 1981-06-30
BG26196A3 (bg) 1979-02-15
FI57585C (fi) 1980-09-10
EG12130A (en) 1978-12-31
US4002641A (en) 1977-01-11
JPS5851953B2 (ja) 1983-11-19
IE40335L (en) 1975-06-20
CA1079728A (en) 1980-06-17
FI366974A (nl) 1975-06-21
HK7977A (en) 1977-02-17
DE2363511A1 (de) 1975-07-10
DK135348C (da) 1977-09-26
ES433148A1 (es) 1977-02-16
SE415834B (sv) 1980-11-03
IL46264A (en) 1979-10-31
NO141850B (no) 1980-02-11
PH12944A (en) 1979-10-18
JPS5095263A (nl) 1975-07-29
NO744421L (nl) 1975-07-14
AU7670474A (en) 1976-07-01
AR209430A1 (es) 1977-04-29
CH613953A5 (nl) 1979-10-31

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO741084L (no) Fremgangsmåte til fremstilling av orale legemiddelpreparater.
NO143218C (no) Analogifremgangsmaate til fremstilling av nonapeptidamider med lh-rh aktivitet
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO740606L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser.
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO141649C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO148376C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser